Results 191 to 200 of about 8,976 (288)

Diversity and evolution of prokaryotic viral lytic proteins. [PDF]

open access: yesISME J
Yang T   +7 more
europepmc   +1 more source

Physical Studies of Muramidase (Lysozyme)

open access: yesJournal of Biological Chemistry, 1964
A.J. Sophianopoulos, K.E. Van Holde
openaire   +1 more source

Genetic analysis of primary lung interdigitating dendritic cell sarcomas

open access: yesThe Journal of Pathology, EarlyView.
Abstract Interdigitating dendritic cell sarcomas (IDCSs) are rare tumors that commonly arise in the hematopoietic system and rarely outside. The genetic drivers of IDCS carcinogenesis are unknown; therefore, therapeutic options are limited. We investigated somatic gene mutations and copy‐number alterations (CNAs) in nine IDCSs arising in the lung by ...
Mikhail S Ermakov   +6 more
wiley   +1 more source

New Perspectives in the Fight Against Multidrug-Resistant Bacteria: The Potential of Endolysin Biocomposites. [PDF]

open access: yesAntibiotics (Basel)
Camacho-González CE   +5 more
europepmc   +1 more source

Biodegradable Dual‐Material 4D‐Printed Scaffolds With Tunable PLA/PEG Ratios for Mandibular Bone Regeneration

open access: yesPolymer Engineering &Science, EarlyView.
Schematic representation of the fabrication and application concept of biodegradable dual‐material 4D‐printed PLA/PEG scaffolds for mandibular bone regeneration. ABSTRACT In this study, biodegradable dual‐material 4D‐printed scaffolds with tunable poly(lactic acid)/poly(ethylene glycol) (PLA/PEG) ratios were designed, fabricated, and systematically ...
Meltem Eryildiz
wiley   +1 more source

A novel peptidoglycan deacetylase modulates daughter cell separation in E. coli. [PDF]

open access: yesPLoS Genet
Hernández-Rocamora VM   +13 more
europepmc   +1 more source

Boron‐10 carriers and their applications in boron neutron capture therapy

open access: yesPrecision Radiation Oncology, EarlyView.
Summary of different types of boron drugs. Abstract Boron neutron capture therapy (BNCT) has emerged as a promising therapeutic modality in cancer treatment, demonstrating the ability to selectively eliminate cancer cells through the 10B(n,α)7Li nuclear reaction with minimal side effects on normal tissues.
Dachao Tang   +7 more
wiley   +1 more source

A case of chronic myelomonocytic related lysozyme-induced nephropathy. [PDF]

open access: yesBMC Nephrol
Kansal A   +6 more
europepmc   +1 more source

The Mycobacterium tuberculosis Rv0132c Gene Product Mtb‐FGD2 Can Act as an F420‐Dependent Glucose Dehydrogenase

open access: yesProteins: Structure, Function, and Bioinformatics, EarlyView.
ABSTRACT The role of the cell envelope‐associated Rv0132c/FGD2 from Mycobacterium tuberculosis has long been a subject of debate. Importantly, FGD2 is found only in pathogenic mycobacteria, making it a potential drug target. While some suggest it functions as a glucose‐6‐phosphate dehydrogenase, others propose it acts instead as an F420‐dependent ...
Adewale V. Aderemi   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy